rs4855559 — MYH15
Intronic variant in the myosin heavy chain 15 gene associated with impaired coronary microvascular function and abnormal coronary flow reserve in men (OR 2.27)
Details
- Gene
- MYH15
- Chromosome
- 3
- Risk allele
- T
- Clinical
- Risk Factor
- Evidence
- Emerging
Population Frequency
Category
Cardiomyopathy & Structural HeartSee your personal result for MYH15
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
MYH15 and Coronary Microvascular Function — A Sex-Specific Risk Variant
The small arteries and capillaries that feed heart muscle — the coronary microcirculation11 coronary microcirculation
vessels less than 500 µm in diameter, responsible for ~70% of total coronary resistance — are increasingly recognized as a distinct
site of cardiovascular disease. Unlike the large coronary arteries that atherosclerosis
typically affects, microvascular dysfunction operates through impaired vasodilation, excessive
vasoconstriction, and structural rarefaction of small vessels. The rs4855559 variant in
MYH15 emerged from a systematic genetic screen of 643 patients as a male-specific
determinant of this underdiagnosed condition.
The Mechanism
MYH15 encodes myosin heavy chain 1522 myosin heavy chain 15
one of the unconventional class II myosin heavy
chains, expressed primarily in extraocular muscles, muscle spindles, and at lower levels
in vascular and cardiac tissue. The rs4855559
variant sits within intron 36 of MYH1533 intron 36 of MYH15
a non-coding region on chromosome 3q13.13,
plus-strand position 108,396,189 in GRCh38.
As an intronic variant, it does not alter the amino acid sequence of the myosin protein.
The likely mechanism is regulatory — altered splicing efficiency, intronic enhancer
disruption, or expression-level effects44 regulatory — altered splicing efficiency, intronic enhancer
disruption, or expression-level effects
the T allele is in linkage disequilibrium with
other MYH15 variants previously associated with myocardial infarction and maladaptive
cardiac remodeling.
Why myosin heavy chain biology would influence coronary microvascular tone is not yet
fully characterized. Candidate mechanisms include altered contractile properties of
vascular smooth muscle cells lining small coronary arteries55 vascular smooth muscle cells lining small coronary arteries
smooth muscle myosin
isoform composition affects vasoconstrictor tone and myogenic reactivity, and indirect effects on cardiomyocyte
contractility that alter microvascular perfusion pressure. The pronounced sex-specificity
of the association — present in men, absent in women — suggests interaction with
androgen-dependent cardiovascular regulatory pathways, though this remains speculative.
The Evidence
Yoshino et al. (2014)66 Yoshino et al. (2014)
Single nucleotide polymorphisms associated with abnormal
coronary microvascular function. Coron Artery Dis 2014;25(4):281-9 conducted the largest candidate-gene study
of coronary microvascular dysfunction to date: 643 patients referred for cardiac
catheterization without significant obstructive coronary disease. Coronary flow reserve
(CFR) was measured by intracoronary adenosine injection77 Coronary flow reserve
(CFR) was measured by intracoronary adenosine injection
CFR below 2.5 defined abnormal
microvascular function, a widely used clinical threshold.
Of 184 patients with abnormal CFR (36 men, 148 women), rs4855559-T was associated with
OR 2.27 for abnormal CFR in men (p=0.0029), with a highly significant sex interaction
(p=0.0008). In women, the association was null (OR 1.22, p=0.22).
A companion MYH15 variant, rs763035288 rs7630352
a second intronic variant in moderate linkage
disequilibrium with rs4855559, showed an even
larger effect in men (OR 2.60, p=0.0006). The convergence of two independent MYH15 variants
on the same male-specific phenotype strengthens the biological signal.
A 2024 systematic review of genetic determinants of coronary microvascular dysfunction99 2024 systematic review of genetic determinants of coronary microvascular dysfunction
Stein et al., J Am Heart Assoc 2024; surveying 30 SNPs across 22 genes from the available
literature confirmed that MYH15 variants
are among the most consistently replicated loci and noted their prior association with
myocardial infarction and maladaptive remodeling. Separately, a large genome-wide
association study (n>28,000 European-ancestry participants) by Purves et al. (2019)1010 Purves et al. (2019)
A major role for common genetic variation in anxiety disorders. Mol Psychiatry 2020 found rs4855559-T genome-wide significantly
associated with lifetime anxiety disorder (beta=0.12 decrease on a continuous anxiety scale,
p=4×10⁻⁸). Whether this reflects shared autonomic regulation between cardiac and anxiety
pathways, or independent pleiotropic effects, is unknown.
Evidence is classified as emerging: the CFR association derives from a single candidate-gene study with a modest sample of men (n=36 with CMD), and has not yet been replicated in an independent cohort with similar methodology. The anxiety GWAS is genome-wide significant but identifies correlation, not causation.
Practical Actions
Men carrying one or two T alleles at rs4855559 have approximately double the odds of
measurable coronary microvascular dysfunction. Because CMD frequently presents as
angina with no obstructive coronary disease — a pattern more common in women but
underdiagnosed in men — awareness of this genetic predisposition should lower the threshold
for physiological testing if symptoms arise. Coronary flow reserve can be assessed
non-invasively using cardiac PET or echocardiography with pharmacological stress1111 Coronary flow reserve can be assessed
non-invasively using cardiac PET or echocardiography with pharmacological stress
these tests quantify microvascular vasodilatory capacity without catheterization.
Microvascular dysfunction responds to interventions targeting endothelial health. Nitrate-rich
vegetables (beetroot, arugula, spinach) raise plasma nitrite and support NO-mediated
vasodilation1212 Nitrate-rich
vegetables (beetroot, arugula, spinach) raise plasma nitrite and support NO-mediated
vasodilation
particularly relevant when endothelial NOS function is impaired in CMD. Phosphodiesterase inhibitors and
ACE inhibitors have shown benefit in small CMD trials. Given the overlap between CMD
and anxiety neurobiology implicated by the GWAS data, autonomic modulation strategies
may also be relevant.
Interactions
The rs4855559 association concentrates in men and interacts multiplicatively with sex (interaction p=0.0008). This marks rs4855559 as one of the few cardiovascular risk variants with a robust, formally tested sex-by-genotype interaction. A second MYH15 intronic variant, rs7630352, appears to act in the same direction with a larger effect size (OR 2.60 in men); individuals carrying T alleles at both variants may face compounded microvascular risk, though this has not been formally tested in a compound genotype analysis.
Genotype Interpretations
What each possible genotype means for this variant:
Common genotype — no MYH15-related microvascular risk signal
You carry two copies of the common G allele at rs4855559 in MYH15. This is the reference genotype, shared by approximately 60% of the global population. Current evidence does not associate this genotype with elevated risk of coronary microvascular dysfunction. No action is needed based on this variant.
One copy of the MYH15 T allele — moderately elevated coronary microvascular risk in men
Heterozygosity at rs4855559 places male carriers at intermediate elevated risk for coronary microvascular dysfunction (CMD). CMD produces angina-like symptoms — exertional chest discomfort, dyspnea — with normal large-artery coronary anatomy on angiography, a presentation frequently labeled "non-obstructive coronary artery disease" (NOCAD). The Yoshino study used CFR <2.5 (measured by intracoronary adenosine) as the diagnostic criterion; this threshold has good specificity for clinically relevant microvascular impairment.
The OR 2.27 for men derives from a subgroup of 36 men with CMD versus a reference group; the modest subgroup size means the confidence interval is wide and the effect size should be interpreted cautiously. Nonetheless, the highly significant sex-interaction p-value (0.0008) adds confidence that the sex-specificity is real rather than a chance stratification finding.
A separate large GWAS (Purves et al. 2019, n>28,000) found rs4855559-T genome-wide significantly associated with lifetime anxiety disorder. If you carry this variant and experience anxiety symptoms, this shared genetic architecture may be relevant for understanding your health profile holistically.
Two copies of the MYH15 T allele — highest microvascular risk signal from this variant in men
Homozygous T/T carriers at rs4855559 have maximal T-allele dose at this locus. The Yoshino et al. study reported an odds ratio of 2.27 per T allele for abnormal coronary flow reserve in men (p=0.0029); under an additive model, homozygotes would be expected to carry approximately 4-fold odds relative to GG carriers, though this was not separately reported for the TT subgroup.
Coronary microvascular dysfunction (CFR <2.5) is associated with adverse cardiac outcomes independent of obstructive coronary artery disease: in prospective studies, impaired CFR predicts major cardiovascular events, heart failure, and all-cause mortality. For men with this genotype experiencing cardiac symptoms, physiological evaluation of microvascular function is particularly warranted.
A companion MYH15 variant, rs7630352, showed an even larger effect (OR 2.60, p=0.0006 in men) in the same study. If you also carry T alleles at rs7630352, the combined evidence for MYH15-related microvascular risk is stronger.